Webcast – MJ Shareholders https://mjshareholders.com The Ultimate Marijuana Business Directory Wed, 10 Aug 2022 18:06:47 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.4 Cannara Biotech Inc. to Host Investor Webcast on August 17th, 2022 https://mjshareholders.com/cannara-biotech-inc-to-host-investor-webcast-on-august-17th-2022/ Wed, 10 Aug 2022 18:06:47 +0000 https://www.cannabisfn.com/?p=2958230

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as “expects”, “will”, “anticipates”, and “estimates”; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief “snapshot” of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled “Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

]]>
Flora Growth to Report Fiscal Year 2021 Results on May 10; Schedules Webcast https://mjshareholders.com/flora-growth-to-report-fiscal-year-2021-results-on-may-10-schedules-webcast/ Fri, 06 May 2022 17:12:00 +0000 https://www.cannabisfn.com/?p=2946779

Ryan Allway

May 6th, 2022

News, Top News


FORT LAUDERDALE, Fla. & TORONTO, May 06, 2022–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today that it will host a webcast on Tuesday, May 10, at 9 a.m. ET, to discuss financial and operating results for its fiscal year ended December 31, 2021.

During the webcast, management will deliver comments on financial results, operational highlights from 2021, and share a brief look at the Company’s performance in 2022 thus far. Following the presentation, Flora will offer analysts, media, and investors the opportunity to ask questions in a question-and-answer session.

Live Webcast Details:

Date: Tuesday, May 10, 2022

Time: 9 am. Eastern Daylight Time

Online Participant Link:

https://floragrowth.com/flora-growth-2021-earnings/

The recording will be available on the Company’s Investor Center page until Aug. 1, 2022.

The live webcast will be available online through the above participant link and will be archived and available on the Company’s website within approximately 24 hours. If any member of the investment community needs access to a phone dial-in, please email [email protected] and one will be provided.

Our latest investor presentation and corporate deck can be found here.

About Flora Growth Corp.
Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that is designed to deliver one of the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.floragrowth.com or follow @floragrowthcorp on social [media] for more information.

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: expected future revenue, the proposed acquisition of Vessel; Vessel’s financial performance; our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220506005106/en/

Contacts

Investor Relations:
James Williams
[email protected]

Public Relations:
Cassandra Dowell
+1 (858) 221-8001
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
High Tide Opens New Canna Cabana Location in Regina, and Provides Timing for Release of Fourth Quarter and Fiscal Year 2021 Financial Results and Webcast https://mjshareholders.com/high-tide-opens-new-canna-cabana-location-in-regina-and-provides-timing-for-release-of-fourth-quarter-and-fiscal-year-2021-financial-results-and-webcast/ Fri, 14 Jan 2022 17:12:12 +0000 https://www.cannabisfn.com/?p=2936601

Ryan Allway

January 14th, 2022


CALGARY, January 14, 2022 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (TSXV: HITI) (Nasdaq: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, announced today that its Canna Cabana retail cannabis store located at 155 Albert Street North in Regina, Saskatchewan, has begun selling recreational cannabis products for adult use. This opening represents High Tide’s 107thbranded retail location across Canada, and 7th in Saskatchewan, selling recreational cannabis products and consumption accessories. Building on the earlier successful launches of two other locations, this store will be the third Canna Cabana to open in Regina, Saskatchewan’s capital and second-largest city. The new Canna Cabana store is located on Albert Street, which is a major north-south thoroughfare and commercial corridor in Regina. It is also one block south of the Northgate Mall, and is easily accessible from several nearby residential communities.

“The Government of Saskatchewan has made the province one of the most attractive for private-sector cannabis retailers, and as a result of their business friendly orientation we will continue to invest in the province,” said Raj Grover, President and Chief Executive Officer of High Tide. “Despite some delays with the building permit approvals process related to the pandemic, I look forward to announcing two additional Regina store openings in the coming weeks. Combined, this growth will make Canna Cabana one of the largest cannabis retailers in the city, and allow us to bring our innovative discount club concept to many more Reginans. Our revamped Cabana Club loyalty program has been well-received by our customers and I’m very encouraged by the results that I have seen so far. I look forward to sharing more information about its progress, as well as our fourth quarter 2021 results, on January 27th,” added Mr. Grover.

RELEASE OF FOURTH QUARTER 2021 RESULTS AND WEBCAST

The Company also announced today that it will release its financial and operational results for the quarter and fiscal year ended October 31, 2021, after financial markets close on Thursday, January 27, 2022. High Tide’s fourth quarter and fiscal year 2021 financial and operational results will be available on SEDAR and on the Company’s website at www.hightideinc.com/invest.

Following the release of its fourth quarter financial and operational results, High Tide will host a webcast and conference call with Raj Grover, President and Chief Executive Officer, and Rahim Kanji, Chief Financial Officer, at 6:00 PM Eastern Time on Thursday, January 27, 2022. The webcast and conference call will discuss High Tide’s fourth quarter and fiscal year 2021 financial and operational results, as well as the Company’s plans for 2022.

Webcast Link for High Tide Earnings Event:

https://events.q4inc.com/attendee/701958923

Participants may pre-register for the webcast by clicking on the link above prior to the beginning of the live webcast. Three hours after the live webcast, a replay of the webcast will be available at the same link above.

Participants may access the audio of the High Tide earnings event through either the new webcast format, or the conference call line below. However, any participant who wishes to ask a question must access the event via conference call, as the webcast does not support live questions.

Dial-In Information:

Canada Dial-In Number (Toll-Free): +1 833 950 0062

Canada Dial-In Number (Local): +1 226 828 7575

United States Dial-In Number (Toll-Free): +1 844 200 6205

United States Dial-In Number (Local): +1 646 904 5544

Dial-In Number for All Other Locations: +1 929 526 1599

Participant Access Code: 037197

*Participants will need to enter the participant access code before being met by a live operator*

ABOUT HIGH TIDE

High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets. The Company is the largest Canadian retailer of recreational cannabis as measured by revenue, with 107 current locations spanning Ontario, Alberta, Manitoba and Saskatchewan, and was featured in the third annual Report on Business Magazine’s ranking of Canada’s Top Growing Companies in 2021. The Company is also North America’s first and only cannabis discount club retailer, featuring Canna Cabana, Meta Cannabis Co., and Meta Cannabis Supply Co. banners, with additional locations under development across the country. High Tide has been serving consumers for over a decade through its established e-commerce platforms including Grasscity.com, Smokecartel.com, Dailyhighclub.com, and Dankstop.com and more recently in the hemp-derived CBD space through Nuleafnaturals.com, FABCBD.com, BlessedCBD.co.uk, and CBDcity.com, as well as its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide’s strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

For more information about High Tide Inc., please visit www.hightideinc.com, its profile page on SEDAR at www.sedar.com, and its profile page on EDGAR at www.sec.gov.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this news release are forward-looking information or forward-looking statements. Such information and statements, referred to herein as “forward-looking statements” are made as of the date of this news release or as of the date of the effective date of information described in this news release, as applicable. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (generally, forward-looking statements can be identified by use of words such as “outlook”, “expects”, “intend”, “forecasts”, “anticipates”, “plans”, “projects”, “estimates”, “envisages, “assumes”, “needs”, “strategy”, “goals”, “objectives”, or variations thereof, or stating that certain actions, events or results “may”, “can”, “could”, “would”, “might”, or “will” be taken, occur or be achieved, or the negative of any of these terms or similar expressions, and other similar terminology) are not statements of historical fact and may be forward-looking statements.

Such forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to the ability of High Tide to execute on its business plan and that High Tide will receive one or multiple licenses from Alberta Gaming, Liquor & Cannabis, British Columbia’s Liquor Distribution Branch, Liquor, Gaming and Cannabis Authority of Manitoba, Alcohol and Gaming Commission of Ontario or the Saskatchewan Liquor and Gaming Authority permitting it to carry on its Canna Cabana Inc. business. High Tide considers these assumptions to be reasonable in the circumstances. However, there can be no assurance that any one or more of the government, industry, market, operational or financial targets as set out herein will be achieved. Inherent in the forward-looking statements are known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements, or industry results, to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements.

The forward‐looking statements contained herein are current as of the date of this news release. Except as required by law, High Tide does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances. Any and all forward-looking statements included in this news release are expressly qualified by this cautionary statement, and except as otherwise indicated, are made as of the date of this news release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933 (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons (as defined in the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration is available.

CONTACT INFORMATION

Media Inquiries

Omar Khan

Senior Vice President – Corporate and Public Affairs

[email protected]

Investor Inquiries

Vahan Ajamian

Capital Markets Advisor

[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Aleafia Health Reports Q3 2021 Financial Results with 123% Increase in Cannabis Net Revenue https://mjshareholders.com/aleafia-health-reports-q3-2021-financial-results-with-123-increase-in-cannabis-net-revenue/ Thu, 11 Nov 2021 16:05:06 +0000 https://www.cannabisfn.com/?p=2935885

Ryan Allway

November 11th, 2021


  • $9.6 million net revenue with an improved sales mix focused on the high-growth adult-use and recurring medical cannabis sales channels
  • 2,044% y/y increase in adult-use cannabis net revenue
  • 31% y/y increase in medical cannabis net revenue
  • Top 10 in national market share in pre-rolls achieved subsequent to the reporting period1
  • Top 10 in national adult-use market share in edibles and oils categories1
  • Outdoor harvest produced average yield on THC-dominant dried flower of 22%
  • SG&A expenses declined 24% over the previous quarter
  • Strengthened product portfolio with a total of 35 and 46 SKUs listed in Ontario and Alberta respectively by January 2022

TORONTO, Nov. 11, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to report its financial results for the three and nine months ended September 30th, 2021. The Company’s 2021 third quarter unaudited, consolidated financial statements and management discussion and analysis will be available in the Investors section of the Company’s website at aleafiahealth.com and will be filed on SEDAR and available at sedar.com.

“Our momentum in the adult-use cannabis sector has continued with our strongest quarter to date by a significant margin,” said Aleafia Health CEO Geoffrey Benic. “Consumer demand for our portfolio has been clearly demonstrated as we now begin to capture meaningful market share, entering the top 10 nationally in the pre-roll, edible, and oils categories. Most importantly, we’ve realized a five-fold sequential increase in dried flower market share during the quarter, in a category that is both Canada’s largest and one that leverages our low-cost cultivation advantage.

“The outdoor cultivation harvest, our third to date, has yielded a material improvement in potency, providing us with a high-quality THC-dominant dried flower for use in our milled and pre-roll product formats. This is expected to significantly improve our available supply of top-selling SKUs, which consistently sell-out in adult-use markets. In 2020, we undertook capital improvements to the outdoor facility while running a cultivar R&D testing program, which has resulted in new, high-potency strains that will enter our portfolio and provide strong momentum heading into the new year.

“Like many of our peers, we have enacted an impairment of goodwill and intangible assets which while negatively affecting net income, are a non-cash expense. We have also undertaken cost review initiatives which have resulted in a sequential decline in SG&A expenses, and we expect will result in additional cost savings in the near term.”

OPERATIONAL HIGHLIGHTS

($,000s, except operational results) Three months ended
Sep 30, 2021 Sep 30, 2020 % Change $ Change
Net adult-use cannabis revenue(1)(2) 5,035 235 2,044% 4,801
Net medical cannabis revenue(1)(2) 2,506 1,909 31% 597
Net bulk wholesale cannabis revenue(1)(2) 1,945 2,101 (7%) (156)
Cannabis net revenue(1)(2) 9,486 4,245 123% 5,242
Active, registered patients 18,642 17,526 6% 1,116
Average net selling price per gram of adult-use cannabis(1) $6.69 $4.92 36% $1.76
Average net selling price per gram of medical cannabis(1) $6.14 $7.91 (22%) ($1.77)
Average net selling price per gram of bulk wholesale cannabis(1) $1.26 $3.85 (67%) ($2.59)
Adjusted gross margin before FV adjustments on adult-use cannabis net revenue(1)(2) 28% 21% 8%
Adjusted gross margin before FV adjustments on medical cannabis net revenue(1)(2) 47% 26% 21%
Adjusted gross margin before FV adjustments on wholesale cannabis net revenue(1)(2) (169%) (9%) (161%)
Kilograms sold 2,709 835 225% 1,874
1. See “Cautionary Statements Regarding Certain non-IFRS Measures” section of associated MD&A for term definition.
2. See associated MD&A for reconciliation to IFRS equivalent.
  • Net cannabis revenue was $9.5 million for the three months ended September 30, 2021 (“Q3 2021”), an increase of 123% over the prior year’s quarter. This was primarily due to an increase in the sale of cannabis in the adult-use and medical cannabis sales channels.
  • Net adult-use cannabis revenue during the three months ended September 30, 2021 was $5.0 million, an increase of 57% over the previous quarter and 2,044% over the prior year’s quarter. The sequential increase was primarily due to greater product availability and the launch of new product formats and SKUs. Specifically, this was driven by increased sales of dried flower and pre-roll products, which make up the largest and third largest adult-use product categories in the Canadian market.
    • Adjusted gross margin in the adult-use cannabis segment before FV adjustments was 28%, compared to 21% in the prior year’s quarter. The sequential decline in gross margin percentage was primarily due to the increase in sales of value priced pre-rolls, which contribute a lower gross margin.
  • Medical cannabis net revenue for Q3 2021 was $2.5 million, a 23% decrease over the previous quarter and a 31% increase over the prior year’s quarter. The sequential decline was due to seasonally lower prescriptions written and filled during the summer months and a decline in international medical cannabis sales during the quarter.
    • Adjusted gross margin in the medical cannabis segment was 47%, compared to 26% in the prior year’s quarter. The improvement was due to optimizations and economies of scale in the production of cannabis products, and from lower costs of input material due to the ramp-up of production at the Niagara Greenhouse and Port Perry outdoor cultivation facilities.
  • Net bulk wholesale revenue received from sales to cannabis licensed producers, as defined in the Cannabis Act was $1.9 million, compared to $3.1 million and $2.1 million in the previous and prior year’s quarters, respectively.
    • The negative gross margin in the bulk wholesale segment during Q3 2021 of 169% is attributable to the Company recording of an inventory provision for slow moving inventory of $2.4 million expensed to cost of sales, and the opportunistic sale of aged CBD distillate, due to a greater focus by the Company on THC dominant SKUs.

PRODUCT LAUNCHES & KEY DEVELOPMENTS

Throughout the reporting period, the Company undertook an expansion of its cannabis brand and product portfolio, including differentiated formats and new SKUs in the important value flower and pre-roll categories.

High Potency Outdoor Cultivation: Subsequent to the reporting period, the Company completed the harvesting of its 2021 outdoor cannabis facility in Port Perry. Testing and weighing of CBD-dominant and CBD/THC balanced cultivars, which represent the vast majority of the total weight harvested, remains underway, and are not reflected in the results below.

Cannabinoid testing results of THC dominant dried flower indicate a significant improvement in potency and total kilograms harvested that can be made available to sell in the adult-use market in pre-roll and milled formats. A total of 11,600 kgs with an average THC potency of 22% will be allocated for sale in the adult-use market, primarily under Aleafia Health’s everyday cannabis brand Divvy. By contrast, in 2020, the Company harvested 7,200 kgs of THC dried flower, but only 7% of this harvest exceeded THC potency of 20%, a key threshold in the adult-use market. The material improvement in potency and yield is attributed to additional cultivars introduced in 2021, following R&D testing in 2020, along with improvements in site infrastructure.

Significant Increase in Dried Flower Market Share: The Company has undertaken an expansion of its dried flower portfolio, the largest product category in the Canadian cannabis market, with new large format SKUs and additional cultivars launched during the reporting period. Strong demand for the Company’s everyday cannabis brand Divvy resulted in an 81-basis point (BPS) increase in national adult-use market share1 over Q2 2021.

Divvy Line Extensions: Following a successful launch of Divvy earlier in 2021, the Company has recently added to the brand portfolio, with additional large format milled and dried flower SKUs. These products lean on Aleafia Health’s low-cost outdoor and greenhouse cultivation advantage with low-cost input material allowing for competitive pricing while protecting gross margins. Additionally, the Company has also recently launched oils under the Divvy banner, which will be available in adult-use markets in Q4 2021.

Top 10 Market Share in Pre-Rolls: Buoyed by continued growth during Q3 2021 in the pre-roll category, the Company sequentially doubled national market share following the launch of larger format SKUs in the value segment under the Divvy brand. Since the close of the reporting period, the Company has entered the top 10 in national market share1 in the category, estimated to be Canada’s third largest.

Top 10 Market Share in Edibles: Through the strength of its Kin Slips sublingual strips2 brand and additional Bogart’s Kitchen confectionary edibles SKUs, the Company has maintained top 10 national market share1 in the edibles category.

Launch of Premium Brand Nith & Grand: Featuring hang dried, hand trimmed, small batch dried flower, and premium concentrates, Nith & Grand appeals to experienced cannabis aficionados. The initial launch features TF Pink Kush Live Resin vape cartridges, which comprises a hydrocarbon extraction process utilizing fresh-frozen cannabis flower that preserves the strain’s natural flavour, aroma and terpene profile.

NET INCOME & ADJUSTED EBITDA

  Three months ended Nine months ended
($,000s) Sep 30, 2021 Sep 30, 2020 Sep 30, 2021 Sep 30, 2020
Net loss (82,922 ) (19,761 ) (94,206 ) (29,937 )
Add back:        
Depreciation and amortization1 2,388 3,273 7,338 7,515
Interest expense, net 1,982 3,062 5,975 8,538
Income tax expense (recovery) (2,854 ) (4,394 ) (2,854 ) (5,394 )
EBITDA (81,406 ) (17,820 ) (83,747 ) (19,278 )
Write-down to net realizable value included in cost of sales(2) 2,382
FV changes in biological assets and changes in inventory sold (3,435 ) 10,708 (6,086 ) 18,027
Share-based payments 1,050 648 2,168 2,108
Bad debt expense 2,225 500 9,944 904
Business transaction costs 865 816 3,379 3,322
Unrealized (gain) loss on marketable securities 6,300 (61 ) 5,600 (66 )
Gain in sale of assets (12,092 )
Impairment of goodwill 11,314 11,314
Impairment of intangible assets 53,093 53,093
Non-operating expense (income) 8 (4 ) (351 ) (407 )
Adjusted EBITDA(3) (7,604 ) (5,213 ) (16,778 ) 4,610
1. Includes non-cash depreciation expensed to cost of sales.
2. See “Note 9” of accompanying financial statements for further discussion.
3. See “Cautionary Statements Regarding Certain non-IFRS Measures” section for term definition.
  • Net loss for the three months ended September 30, 2021 was $82.9 million compared to a net loss of $19.8 million over the prior year’s quarter. The increase in net loss over the prior year’s quarter is primarily due non-cash items including a $53.1 million impairment of intangible assets and a $11.3 million impairment of goodwill.
  • During Q3 2021, wages & benefits, and selling & administrative expenses were $7.0 million, a decline of 24% over the previous quarter. This follows cost review initiatives undertaken during the reporting period which remain ongoing.
  • Adjusted EBITDA for the three months ended September 30, 2021 was a loss of $7.6 million, compared to a loss of $5.2 million in the prior year’s quarter. The decline over the prior year’s quarter was primarily due to an increase in cost of sales, which relates to the one-time sale of aged inventory in the bulk wholesale channel.

SELECTED BALANCE SHEET INFORMATION

($,000s) Sep 30, 2021 Dec 31, 2020
Cash, cash equivalents, marketable securities 11,338 30,529
Current assets 69,894 82,923
Current liabilities 65,750 45,041
Working capital 4,144 37,882
Total assets 152,708 237,283
Total liabilities 67,768 83,062
Capitalization
Lease liability 2,533 3,167
Credit Facility 9,942
Convertible debt 34,741 56,802
Total debt 47,216 59,969
Total equity 84,940 154,221
Total capitalization 132,156 214,190

CONFERENCE CALL & WEBCAST

Date:   November 11, 2021
Time:   9:30 a.m. ET
USA/Canada Toll-Free Participant Call-in: (866) 679-9046; Passcode: 5588397
International Toll-Free Participant Call-in: (409) 217-8323; Passcode: 5588397
WEBCAST LINK

This conference call will be webcast live over the internet and can be accessed through the link provided. Audio of the call will be available to participants through both the conference call line and webcast; however, the presentation may only be viewed via the webcast. Participants who miss the live call can view a replay at any time via the link provided.

  1. According to retail sell-through data from Hifyre, inclusive of Ontario, Alberta, BC and Saskatchewan.
  2. Hifyre data classifies Kin Slips in the edibles product category.

CAUTIONARY STATEMENT REGARDING NON-IFRS MEASURES

This press release contains non-IFRS financial performance measures which the Company believes provides users with relevant information regarding operation performance. These measures are not recognized or defined under IFRS, and as a result, they may not be comparable to the data presented by competitors. For term definitions and reconciliation to IFRS equivalent, please see the associated Q3 2021 MD&A.

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
[email protected]
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada. The Company has developed an international footprint, with subsidiaries or investments in German and Australian medical cannabis companies and has products available in both markets. The Company owns and operates a virtual network of medical cannabis clinics staffed by physicians and nurse practitioners who have seen over 75,000 patients to date.

Aleafia Health owns three licensed cannabis production facilities and operates a strategically located distribution centre all in the province of Ontario, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of cannabis derivative products including oils, capsules, edibles, sublingual strips, and vapes, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>